Ezoleta

Medicinal product

(Invented) name

Ezoleta

Active substance (s)

Ezetimibas

Strength

10 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

C10AX09, Ezetimibe

Marketing authorisation holder

UAB Ideal Trade Links, Lietuva

Date of authorisation

2021-11-22

Date of renewal

Documents

1622_Ezoleta_2024-07-16_K.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Ezetimibas	10 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
107576	93681	1093681	lizdinė plokštelė	N10		Receptinis	LT/L/21/1622/001	Netiekiama	-	-	No	-	-	Download
107577	93682	1093682	lizdinė plokštelė	N30		Receptinis	LT/L/21/1622/002	Netiekiama	2024-12-17	2025-12-31	Yes	2025-01-01	2025-11-01
107578	93683	1093683	lizdinė plokštelė	N50		Receptinis	LT/L/21/1622/003	Netiekiama	-	-	No	-	-
107579	93684	1093684	lizdinė plokštelė	N60		Receptinis	LT/L/21/1622/004	Tiekiama	-	-	No	-	-
107580	93685	1093685	lizdinė plokštelė	N90		Receptinis	LT/L/21/1622/005	Netiekiama	-	-	No	-	-
107581	93686	1093686	lizdinė plokštelė	N100		Receptinis	LT/L/21/1622/006	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2021-11-22	Registruotas